PDF format as a courtesy.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 31, 2010

Cardo Medical, Inc.
(Exact Name of Registrant as Specified in Its Charter)

 

Delaware	0-21419	23-2753988
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

9701 Wilshire Blvd., Suite 1100
Beverly Hills, California    90212
(Address of Principal Executive Offices Including Zip Code)

(310) 274-2036
(Registrant's Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

EXPLANATORY NOTE

This Current Report on Form 8-K is filed solely for the purpose of filing the consent of Stonefield Josephson, Inc., which consent was inadvertently omitted from Cardo Medical, Inc.'s (the "Company") Annual Report on Form 10-K for the fiscal year ended December 31, 2009, filed with the Securities and Exchange Commission on March 31, 2010 (the "Form 10-K"). The consent relates to the incorporation by reference in the Company's Registration Statement on Form S-3 (Registration No. 333-164759) of Stonefield Josephson, Inc.'s Independent Registered Public Accounting Firm's Report, dated March 31, 2010, which report was included in the Form 10-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
23.1		Consent of Stonefield Josephson, Inc.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CARDO MEDICAL, INC.

Date: August 12, 2010 By:   /s/ Derrick Romine

       Derrick Romine

       Chief Financial Officer

3

EXHIBIT INDEX

Exhibit Number		Description
23.1		Consent of Stonefield Josephson, Inc.      Also provided in PDF format as a courtesy.

4